OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer
Jianjun Li, Xuechun Xiao, Yang Ou, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 765-787
Open Access | Times Cited: 22

Showing 22 citing articles:

Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
Hongli Gao, Jianqiao Yin, Ce Ji, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 51

Recent Advances in Small Molecule Inhibitors of Deubiquitinating Enzymes
Pengwei Liu, Zhengyang Chen, Yiting Guo, et al.
European Journal of Medicinal Chemistry (2025), pp. 117324-117324
Closed Access | Times Cited: 4

Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10

PD-L1 induces autophagy and primary resistance to EGFR–TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway
Na Li, Ran Zuo, Yuchao He, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 10

Berbamine promotes ferroptosis of esophageal squamous cell carcinoma by facilitating USP51-mediated GPX4 ubiquitination and degradation
Hao Peng, YuanPeng He, Yuepeng Hu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117309-117309
Open Access | Times Cited: 4

The Hidden Potential of Solasonine: Targeting Non-Small Cell Lung Cancer (NSCLC) Metastasis Through GATM and Smad2 Pathways
Cheng Hu, Jiaqi Zhang, Xiaoyu Zhuang, et al.
Phytomedicine (2025) Vol. 139, pp. 156455-156455
Closed Access

Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date
Mengdi Liang, Yang Huang, Shengfeng Huang, et al.
Molecular Diagnosis & Therapy (2025)
Closed Access

Emerging role of deubiquitinases in modulating cancer chemoresistance
Sukeerthi Dasharathy, Pranay, Santhosh K Devdas, et al.
Drug Discovery Today (2025), pp. 104339-104339
Closed Access

Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications
Yoshinobu Kariya, Michiru Nishita
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3143-3143
Open Access

Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemia
Chiharu Ishikawa, Laura Barreyro, Avery Sampson, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 10
Open Access

Assessing the metastatic potential of circulating tumor cells using an organ-on-chip model
Karin Farah Schmid, Soheila Zeinali, Susanne Karoline Moser, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access

USP5 Stabilizes IKBKG Through Deubiquitination to Suppress Ferroptosis and Promote Growth in Non-small Cell Lung Cancer
Yufu Li, Gan Qiu, Min Zhou, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access

Page 1

Scroll to top